Archive for the ‘rejuvenation’ tag
Oct 23, 2019
Dr. Josh Mitteldorf — DataBETA Project — Population Scale Longevity Clinical Trials — ideaXme — Ira Pastor
Posted by Ira S. Pastor in categories: aging, bioengineering, biotech/medical, genetics, health, life extension, neuroscience, posthumanism, science, transhumanism
Sep 16, 2019
The Regenerage Show- Episode #4 — “Whole Organism Rejuvenation and Combinatorial Biologics” — Ira Pastor — Host
Posted by Ira S. Pastor in categories: aging, bioengineering, biotech/medical, business, DNA, futurism, health, Peter Diamandis, science, transhumanism
Sep 5, 2019
Johannon BenZion — Ira Pastor — Futurist New Deal Podcast — “Harnessing Nature’s Clues for Regeneration, Disease Reversion, and Rejuvenation”
Posted by Ira S. Pastor in categories: aging, bioengineering, biotech/medical, business, cryonics, futurism, genetics, geopolitics, government, health
Jul 19, 2019
Regenerage International, IIMET, and Bioquark Inc. to Collaborate on Clinical Study in Biologic Age Reversal of Photodamaged Skin
Posted by Ira S. Pastor in categories: aging, bioengineering, biotech/medical, business, chemistry, DNA, genetics, health, life extension, science
https://www.prweb.com/releases/regenerage_international_iime…449142.htm
May 13, 2016
Bringing The Dead Back To Life — Reanima Project / Bioquark Inc. Media Coverage
Posted by Ira S. Pastor in categories: aging, bioengineering, biological, cryonics, disruptive technology, futurism, health, life extension, neuroscience, transhumanism
Fox 29 — Good Day Philadelphia
http://www.fox29.com/140735577-video
NBC TV 10
Continue reading “Bringing The Dead Back To Life — Reanima Project / Bioquark Inc. Media Coverage” »
Apr 20, 2016
Bioquark Inc. and Revita Life Sciences Receive IRB Approval for First-In-Human Brain Death Study
Posted by Ira S. Pastor in categories: aging, bioengineering, biological, biotech/medical, cryonics, disruptive technology, futurism, health, life extension, neuroscience
Bioquark, Inc., (http://www.bioquark.com) a company focused on the development of novel biologics for complex regeneration and disease reversion, and Revita Life Sciences, (http://revitalife.co.in) a biotechnology company focused on translational therapeutic applications of autologous stem cells, have announced that they have received IRB approval for a study focusing on a novel combinatorial approach to clinical intervention in the state of brain death in humans.
This first trial, within the portfolio of Bioquark’s Reanima Project (http://www.reanima.tech) is entitled “Non-randomized, Open-labeled, Interventional, Single Group, Proof of Concept Study With Multi-modality Approach in Cases of Brain Death Due to Traumatic Brain Injury Having Diffuse Axonal Injury” (https://clinicaltrials.gov/ct2/show/NCT02742857?term=bioquark&rank=1), will enroll an initial 20 subjects, and be conducted at Anupam Hospital in Rudrapur, Uttarakhand India.
Mar 21, 2016
Resurrection and Biotechnology
Posted by Ira S. Pastor in categories: biotech/medical, disruptive technology, Elon Musk, futurism, human trajectories, neuroscience, posthumanism, Ray Kurzweil, Skynet, transhumanism
“He is not here; He has risen,” — Matthew 28:6
As billions of Christians around the world are getting ready to celebrate the Easter festival and holiday, we take pause to appreciate the awe inspiring phenomena of resurrection.
In religious and mythological contexts, in both Western and Eastern societies, well known and less common names appear, such as Attis, Dionysus, Ganesha, Krishna, Lemminkainen, Odin, Osiris, Persephone, Quetzalcoatl, and Tammuz, all of whom were reborn again in the spark of the divine.
Mar 9, 2016
Death Reversal — The Reanima Project — Research Whose Time Has Come
Posted by Ira S. Pastor in categories: aging, biotech/medical, business, cryonics, health, life extension, neuroscience, posthumanism, science, scientific freedom
I have spent the last 30 years in various aspects of the biopharmaceutical industry, which for the most part has been a very rewarding experience.
However, during this time period, having been immersed many different components of therapeutic development and commercialization, one thing has always bothered me: a wide array of promising research never makes it off the bench to see the translational light of day, and gets lost in the historical scientific archives.
I always believed that scientific progress happened in a very linear narrative, with each new discovery supporting the next, resulting ultimately in an eventual stairway of scientific enlightenment.
Continue reading “Death Reversal — The Reanima Project — Research Whose Time Has Come” »
